Advert - Strides Pharma
Promotion of Strivit D3 on LinkedIn
Date posted12 March 2021
For promoting Strivit D3 (colecalciferol) on LinkedIn, Strides Pharma was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 9.1 - Failing to maintain high standards
Clause 26.1 - Advertising a prescription only medicine to the public.